This finding contradicts the majority of previously reported studies (Rocca et al., 2019; Gonzalez-Romero et al., 2021; Li et al., 2023) that conclude E2F1 as an oncogene, providing a reference for further investigation into the varying roles of E2F1 in different cancers. This evidence concerns the gene E2F1 and cancer.